These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2454656)

  • 1. Kinetic analysis of the folding and unfolding of a mutant form of bovine pancreatic trypsin inhibitor lacking the cysteine-14 and -38 thiols.
    Goldenberg DP
    Biochemistry; 1988 Apr; 27(7):2481-9. PubMed ID: 2454656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
    Ma LC; Anderson S
    Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide bond-coupled folding of bovine pancreatic trypsin inhibitor derivatives missing one or two disulfide bonds.
    Kosen PA; Marks CB; Falick AM; Anderson S; Kuntz ID
    Biochemistry; 1992 Jun; 31(25):5705-17. PubMed ID: 1377024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denaturant-dependent folding of bovine pancreatic trypsin inhibitor mutants with two intact disulfide bonds.
    Hurle MR; Marks CB; Kosen PA; Anderson S; Kuntz ID
    Biochemistry; 1990 May; 29(18):4410-9. PubMed ID: 1693524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early events in the disulfide-coupled folding of BPTI.
    Bulaj G; Goldenberg DP
    Protein Sci; 1999 Sep; 8(9):1825-42. PubMed ID: 10493584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of hydrogen bonding residues in the BPTI folding pathway.
    Bulaj G; Goldenberg DP
    J Mol Biol; 2001 Oct; 313(3):639-56. PubMed ID: 11676545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutants of bovine pancreatic trypsin inhibitor lacking cysteines 14 and 38 can fold properly.
    Marks CB; Naderi H; Kosen PA; Kuntz ID; Anderson S
    Science; 1987 Mar; 235(4794):1370-3. PubMed ID: 2435002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates.
    Darby NJ; Morin PE; Talbo G; Creighton TE
    J Mol Biol; 1995 Jun; 249(2):463-77. PubMed ID: 7540214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
    Liu Y; Breslauer K; Anderson S
    Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amino acid replacements on the reductive unfolding kinetics of pancreatic trypsin inhibitor.
    Mendoza JA; Jarstfer MB; Goldenberg DP
    Biochemistry; 1994 Feb; 33(5):1143-8. PubMed ID: 7509189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
    Krokoszynska I; Dadlez M; Otlewski J
    J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid replacement that eliminates kinetic traps in the folding pathway of pancreatic trypsin inhibitor.
    Zhang JX; Goldenberg DP
    Biochemistry; 1993 Dec; 32(51):14075-81. PubMed ID: 7505111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of DsbA on the disulfide folding of bovine pancreatic trypsin inhibitor and alpha-lactalbumin.
    Zapun A; Creighton TE
    Biochemistry; 1994 May; 33(17):5202-11. PubMed ID: 7513556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the disulfide-coupled folding pathway of BPTI by circular permutation.
    Bulaj G; Koehn RE; Goldenberg DP
    Protein Sci; 2004 May; 13(5):1182-96. PubMed ID: 15096625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native-like interactions favored in the unfolded bovine pancreatic trypsin inhibitor have different roles in folding.
    Li R; Battiste JL; Woodward C
    Biochemistry; 2002 Feb; 41(7):2246-53. PubMed ID: 11841216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic interactions accelerate early stages of the folding of BPTI.
    Dadlez M
    Biochemistry; 1997 Mar; 36(10):2788-97. PubMed ID: 9062106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phi-values for BPTI folding intermediates and implications for transition state analysis.
    Bulaj G; Goldenberg DP
    Nat Struct Biol; 2001 Apr; 8(4):326-30. PubMed ID: 11276252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfolding and refolding of the native structure of bovine pancreatic trypsin inhibitor studied by computer simulations.
    Hao MH; Pincus MR; Rackovsky S; Scheraga HA
    Biochemistry; 1993 Sep; 32(37):9614-31. PubMed ID: 7690589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability.
    Kowalski JM; Parekh RN; Wittrup KD
    Biochemistry; 1998 Feb; 37(5):1264-73. PubMed ID: 9477952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic role of nonnative species in the folding of bovine pancreatic trypsin inhibitor.
    Weissman JS; Kim PS
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9900-4. PubMed ID: 1384063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.